Balázs Dome

19PUBLICATIONS
80CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 04, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

|Jan 28, 2026
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Muhammad Hashim, Gerald Timelthaler, Dominik Kirchhofer

|Dec 18, 2025
Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Kristiina Boettiger, Ildikó Kovács, Lilla Horvath

|Dec 14, 2025
Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer.

Büsra Ernhofer, Anna Solta, Julia Sinner

|Sep 11, 2025
Clinical Significance of Time-to-Surgery and COVID-19 Pandemic in Surgically Treated Non-Small Cell Lung Cancer.

Áron Ghimessy, János Fillinger, Márton Csaba

|Sep 04, 2025
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.

Karin Schelch, Nadine Maach, Muhammad Hashim

Pageof 4

Frequent Collaborators

9 joint publications

Michael Grusch

6 joint publications

Clemens Aigner

5 joint publications

Karin Schelch

4 joint publications

Mir Alireza Hoda